Cargando…
In Vivo Study of the Efficacy and Safety of 5-Aminolevulinic Radiodynamic Therapy for Glioblastoma Fractionated Radiotherapy
To treat malignant glioma, standard fractionated radiotherapy (RT; 60 Gy/30 fractions over 6 weeks) was performed post-surgery in combination with temozolomide to improve overall survival. Malignant glioblastoma recurrence rate is extremely high, and most recurrent tumors originate from the excision...
Autores principales: | Takahashi, Junko, Nagasawa, Shinsuke, Doi, Motomichi, Takahashi, Masamichi, Narita, Yoshitaka, Yamamoto, Junkoh, Ikemoto, Mitsushi J., Iwahashi, Hitoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470662/ https://www.ncbi.nlm.nih.gov/pubmed/34575921 http://dx.doi.org/10.3390/ijms22189762 |
Ejemplares similares
-
Verification of 5-Aminolevurinic Radiodynamic Therapy Using a Murine Melanoma Brain Metastasis Model
por: Takahashi, Junko, et al.
Publicado: (2019) -
An Orthotopic Model of Glioblastoma Is Resistant to Radiodynamic Therapy with 5-AminoLevulinic Acid
por: Dupin, Charles, et al.
Publicado: (2022) -
Verification of radiodynamic therapy by medical linear accelerator using a mouse melanoma tumor model
por: Takahashi, Junko, et al.
Publicado: (2018) -
DNA Strand Break Properties of Protoporphyrin IX by X-ray Irradiation against Melanoma
por: Hasegawa, Takema, et al.
Publicado: (2020) -
5-Aminolevulinic acid enhances cancer radiotherapy in a mouse tumor model
por: Takahashi, Junko, et al.
Publicado: (2013)